These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38162959)

  • 41. Rapid Real-time Tracking of Nonpharmaceutical Interventions and Their Association With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity: The Coronavirus Disease 2019 (COVID-19) Pandemic Pulse Study.
    Clipman SJ; Wesolowski AP; Gibson DG; Agarwal S; Lambrou AS; Kirk GD; Labrique AB; Mehta SH; Solomon SS
    Clin Infect Dis; 2021 Oct; 73(7):e1822-e1829. PubMed ID: 32877921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing the impact of adherence to Non-pharmaceutical interventions and indirect transmission on the dynamics of COVID-19: a mathematical modelling study.
    Iyaniwura SA; Rabiu M; David JF; Kong JD
    Math Biosci Eng; 2021 Oct; 18(6):8905-8932. PubMed ID: 34814328
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimating the burden of lung cancer and the efficiency of home radon mitigation systems in some Canadian provinces.
    Al-Arydah M
    Sci Total Environ; 2018 Jun; 626():287-306. PubMed ID: 29353778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring the percentage of COVID-19 cases reported in the community in Canada and associated case fatality ratios.
    Dougherty BP; Smith BA; Carson CA; Ogden NH
    Infect Dis Model; 2021; 6():123-132. PubMed ID: 33313456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Social Contacts and Transmission of COVID-19 in British Columbia, Canada.
    Ringa N; Iyaniwura SA; David S; Irvine MA; Adu P; Spencer M; Janjua NZ; Otterstatter MC
    Front Public Health; 2022; 10():867425. PubMed ID: 35592086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health.
    O'Brien SF; Caffrey N; Yi QL; Bolotin S; Janjua NZ; Binka M; Thanh CQ; Stein DR; Lang A; Colquhoun A; Pambrun C; Reedman CN; Drews SJ
    Microbiol Spectr; 2023 Feb; 11(1):e0335622. PubMed ID: 36625634
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unintended Consequences of COVID-19 Non-Pharmaceutical Interventions (NPIs) for Population Health and Health Inequalities.
    ÓhAiseadha C; Quinn GA; Connolly R; Wilson A; Connolly M; Soon W; Hynds P
    Int J Environ Res Public Health; 2023 Mar; 20(7):. PubMed ID: 37047846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes Among Patients Hospitalized With Non-COVID-19 Conditions Before and During the COVID-19 Pandemic in Alberta and Ontario, Canada.
    McAlister FA; Chu A; Qiu F; Dong Y; van Diepen S; Youngson E; Yu AYX; de Mestral C; Ross HJ; Austin PC; Lee DS; Kadri SS; Wijeysundera HC;
    JAMA Netw Open; 2023 Jul; 6(7):e2323035. PubMed ID: 37436751
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of Non-Pharmaceutical Interventions to Reduce the Spread of SARS-CoV-2 With Anxiety and Depressive Symptoms: A Multi-National Study of 43 Countries.
    Riehm KE; Badillo Goicoechea E; Wang FM; Kim E; Aldridge LR; Lupton-Smith CP; Presskreischer R; Chang TH; LaRocca S; Kreuter F; Stuart EA
    Int J Public Health; 2022; 67():1604430. PubMed ID: 35308051
    [No Abstract]   [Full Text] [Related]  

  • 50. The stringency of the containment measures in response to COVID-19 inversely correlates with the overall disease occurrence over the epidemic wave.
    Mezencev R; Klement C
    Bratisl Lek Listy; 2022; 123(9):601-617. PubMed ID: 36039877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modeling the evolution of SARS-CoV-2 under non-pharmaceutical interventions and testing.
    Gurevich Y; Ram Y; Hadany L
    Evol Med Public Health; 2022; 10(1):179-188. PubMed ID: 35498119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Significant relaxation of SARS-CoV-2-targeted non-pharmaceutical interventions may result in profound mortality: A New York state modelling study.
    Hoffman BU
    PLoS One; 2020; 15(9):e0239647. PubMed ID: 32970745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adherence to and enforcement of non-pharmaceutical interventions (NPIs) for COVID-19 prevention in Nigeria, Rwanda, and Zambia: A mixed-methods analysis.
    Solomon H; Thea DM; Galea S; Sabin LL; Lucey DR; Hamer DH
    PLOS Glob Public Health; 2022; 2(9):e0000389. PubMed ID: 36962721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-pharmaceutical interventions for COVID-19 reduced the incidence of infectious diseases: a controlled interrupted time-series study.
    Zhang W; Wu Y; Wen B; Zhang Y; Wang Y; Yin W; Sun S; Wei X; Sun H; Zhang Z; Li S; Guo Y
    Infect Dis Poverty; 2023 Mar; 12(1):15. PubMed ID: 36895021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An ecological analysis of long-term exposure to PM
    Stieb DM; Evans GJ; To TM; Brook JR; Burnett RT
    Environ Res; 2020 Dec; 191():110052. PubMed ID: 32860780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis.
    Willows S; Alam SB; Sandhu JK; Kulka M
    Biochem Cell Biol; 2021 Apr; 99(2):173-194. PubMed ID: 33027600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of multi-level interventions on the second-wave SARS-CoV-2 transmission in China.
    He Y; Chen Y; Yang L; Zhou Y; Ye R; Wang X
    PLoS One; 2022; 17(9):e0274590. PubMed ID: 36112630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human choice to self-isolate in the face of the COVID-19 pandemic: A game dynamic modelling approach.
    Ngonghala CN; Goel P; Kutor D; Bhattacharyya S
    J Theor Biol; 2021 Jul; 521():110692. PubMed ID: 33771612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of recreational cannabis legalization on rates of traffic injury in Canada.
    Walker M; Saarela O; Mann R; Carpino M; Cusimano MD
    Addiction; 2023 Aug; 118(8):1517-1526. PubMed ID: 36908044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.